| Authors: |
Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Podoltsev NA; Yale School of Medicine, New Haven, CT, USA. nikolai.podoltsev@yale.edu., Othus M; SWOG Statistics and Data Management Center, Seattle, WA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Rizzieri DA; Duke University Medical Center, Durham, NC, USA., Marcucci G; Ohio State University (Alliance), Columbus, OH, USA.; City of Hope, Duarte, CA, USA., Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Savoie ML; Tom Baker Cancer Centre, Calgary, AB, Canada., Medeiros BC; Stanford University, Stanford, CA, USA., Sekeres MA; Cleveland Clinic, Cleveland, OH, USA.; University of Miami, Maiami, FL, USA., Lin TL; University of Kansas Medical Center, Kansas City, KS, USA., Uy GL; Washington University School of Medicine, St. Louis, USA., Powell BL; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kolitz JE; North Shore University Hospital, Manhasset, NY, USA., Larson RA; University of Chicago, Chicago, IL, USA., Stone RM; Dana Farber Cancer Institute, Boston, MA, USA., Claxton D; Pennsylvania State Milton S Hershey Medical Center, Hummelstown, USA., Essell J; Jewish Hospital, Cincinnati, OH, USA., Luger SM; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Mohan SR; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Moseley A; SWOG Statistics and Data Management Center, Seattle, WA, USA., Appelbaum FR; Fred Hutchinson Cancer Center, Seattle, WA, USA., Erba HP; Duke University Cancer Center, Durham, NC, USA. |
